Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Prostate Cancer|March 28, 2013
Analysis of preoperative detection for apex prostate cancer by transrectal biopsyTomokazu Sazuka, Takashi Imamoto, Takeshi Namekawa, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 19, 2022
[SIGNIFICANCE OF IgG4 IN IDIOPATHIC RETROPERITONEAL FIBROSIS]Masaaki Sanda, Naoto Kamiya, Yuka Sugizaki, et al.Current Oncology (Toronto, Ont.)|December 24, 2025
Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic ImplicationsTakatoshi Somoto, Takanobu Utsumi, Rino Ikeda, et al.Cancers|October 29, 2025
Navigating Therapeutic Landscapes in Urothelial Cancer: From Chemotherapy to Precision Immuno-OncologyTakatoshi Somoto, Takanobu Utsumi, Rino Ikeda, et al.Lower Urinary Tract Symptoms|December 15, 2015
Clinical Impact of Solifenacin on Generic and Symptom-Specific Quality of Life for Females with Overactive Bladder: Using the Overactive Bladder Symptom Score and Rand Medical Outcomes Study 36-Item Health SurveyMasashi Yano, Hiroyoshi Suzuki, Naoto Kamiya, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2025
Impact of the COVID-19 Pandemic on Prostate Cancer: Perturbations in Screening and Diagnostic PatternsTakahide Noro, Takanobu Utsumi, Naoki Ishitsuka, et al.Journal of Personalized Medicine|October 28, 2025
External Validation and Comparative Performance of the T.O.HO. and S.T.O.N.E. Scoring Systems for Predicting Stone-Free Outcomes Following Flexible Ureteroscopy: Toward Personalized Preoperative CounselingYuka Sugizaki, Takanobu Utsumi, Rino Ikeda, et al.Cancers|February 27, 2026
Chemotherapy-Forward Management of Advanced Prostate Cancer: Taxane Timing, Sequencing and the Real-World Place of ImmunotherapyTakahide Noro, Takanobu Utsumi, Rino Ikeda, et al.Clinical Genitourinary Cancer|October 19, 2017
Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate CancerNobuaki Matsubara, Yoko Yamada, Ken-Ichi Tabata, et al.Clinical Genitourinary Cancer|August 23, 2017
Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate CancerNobuaki Matsubara, Yoko Yamada, Ken-Ichi Tabata, et al.Pageof 9